You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for LEVONORGESTREL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for LEVONORGESTREL

Average Pharmacy Cost for LEVONORGESTREL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB 42192-0623-28 5.25368 EACH 2025-01-22
LEVONORGESTREL 1.5 MG TABLET 00536-1142-63 6.01890 EACH 2025-01-22
LEVONORGESTREL 1.5 MG TABLET 70700-0164-06 6.01890 EACH 2025-01-22
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET 68180-0843-11 0.14191 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LEVONORGESTREL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEVONORGESTREL (EQV-PLAN B) 1.5MG TAB,PKG,1 Curae Pharma360, Inc. 73358-0911-01 1 5.03 5.03000 EACH 2023-07-15 - 2028-07-14 FSS
LEVONORGESTREL (EQV-PLAN B) 1.5MG TAB,PKG,1 AvKare, LLC 70700-0164-06 1 18.09 18.09000 EACH 2023-06-15 - 2028-06-14 FSS
KYLEENA Bayer HealthCare Pharmaceuticals, Inc. 50419-0424-01 1 859.38 859.38000 EACH 2022-01-01 - 2025-09-28 FSS
SKYLA 13.5MG LEVONORGESTREL Bayer HealthCare Pharmaceuticals, Inc. 50419-0422-01 1 466.12 466.12000 EACH 2023-01-01 - 2025-09-28 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Levonorgestrel

Introduction to Levonorgestrel

Levonorgestrel is a progestin hormone widely used in various forms of contraceptives, including oral tablets, injectables, and hormone-releasing intrauterine devices (IUDs). It is a crucial component in birth control and emergency contraception, as well as in managing heavy menstrual bleeding.

Global Market Size and Growth

The global levonorgestrel market is projected to experience steady growth over the coming years. Here are some key projections:

  • By 2029, the global levonorgestrel market is expected to reach $84.35 million, with a Compound Annual Growth Rate (CAGR) of 3.94% from 2023 to 2030[1].
  • Another report indicates that the market will touch USD 0.068 billion by 2032, growing at a CAGR of 3.3%[2].

Driving Factors

Several factors are driving the growth of the levonorgestrel market:

  • Increasing Awareness and Utilization: Growing awareness among people about the benefits of hormonal contraceptives, particularly during menopause, is a significant driver. This increased awareness leads to higher utilization rates, contributing to market growth[2].
  • Innovative Products and R&D: Continuous research and development to create innovative contraceptive products, such as more effective and user-friendly IUDs, are boosting the market. Supportive government initiatives in developing and underdeveloped countries also play a crucial role[3].
  • Medical Care Infrastructure: Robust medical care systems, especially in regions like North America, contribute to the market's growth by ensuring better access to these contraceptives[4].

Market Segmentation

The levonorgestrel market is segmented based on type and application:

  • By Type: The market is segmented into short-acting contraceptive APIs and long-acting contraceptive APIs. The short-acting contraceptive API segment is currently the major contributor due to the widespread use of oral contraceptive pills and injectables[4].
  • By Application: The market is segmented into levonorgestrel tablets, mixture products, and hormone-releasing IUDs. The hormone-releasing IUD segment is expected to witness rapid growth due to its high effectiveness and additional benefits such as alleviating heavy or painful periods[4].

Regional Analysis

The market is geographically segmented, with different regions showing varying growth rates:

  • North America: This region is expected to hold a significant revenue share due to its robust healthcare system and rising healthcare costs[4].
  • Asia Pacific: This region is projected to grow rapidly due to the increasing population of women, strong policies supporting contraceptive use, and fertility rates[4].

Competitive Landscape

The levonorgestrel market is competitive, with several key players:

  • Bayer HealthCare: Known for its extensive range of contraceptive products.
  • Paladin Labs: Another major player in the hormonal contraceptives market.
  • Foundation Consumer Healthcare: Offers a variety of contraceptive solutions.
  • Theramex (Teva): A significant player with a broad portfolio of hormonal contraceptives.
  • Pfizer: A global pharmaceutical giant with a strong presence in the market.
  • Lupin: A global pharmaceutical company with recent developments in the US market[2][4].

Price Projections and Cost Analysis

The cost of levonorgestrel can vary based on the form and dosage:

  • Oral Tablets: The cost for a 1.5 mg oral tablet of levonorgestrel is around $17 for a single tablet, depending on the pharmacy[5].
  • Patient Assistance Programs: While there are no specific patient assistance programs for levonorgestrel, healthcare providers may have information on available programs in their area[5].

Challenges and Restraints

Despite the growth, the market faces several challenges:

  • High-Cost Criteria: The high costs associated with the safety and health of levonorgestrel APIs can be a significant barrier. Additionally, the need for substantial upfront investment in large-scale applications hampers market expansion[4].
  • Supply Chain Disruptions: The COVID-19 pandemic has caused supply chain disruptions, affecting the sales of API commodities[4].

Recent Developments

  • Bayer and Google Cloud Partnership: In January 2024, Bayer partnered with Google Cloud to leverage AI solutions, particularly in radiology, which could indirectly benefit their contraceptive product development[4].
  • Lupin's Generic Version of Oracea: In March 2024, Lupin launched the first generic version of Oracea (Doxycycline Capsules, 40 mg) in the US market after receiving FDA clearance[4].

Key Takeaways

  • The global levonorgestrel market is expected to grow significantly, reaching $84.35 million by 2029 and $0.068 billion by 2032.
  • The market is driven by increasing awareness, innovative products, and robust medical care infrastructure.
  • The short-acting contraceptive API segment currently dominates the market, but the hormone-releasing IUD segment is expected to grow rapidly.
  • North America and Asia Pacific are key regions contributing to the market's growth.
  • Major players include Bayer, Paladin Labs, Foundation Consumer Healthcare, and Pfizer.

FAQs

1. What is the projected size of the global levonorgestrel market by 2029? The global levonorgestrel market is expected to reach $84.35 million by 2029[1].

2. What is the CAGR of the levonorgestrel market from 2023 to 2032? The levonorgestrel market is expected to exhibit a CAGR of 3.3% from 2023 to 2032[2].

3. Which segment is expected to hold the largest share in the levonorgestrel API market? The short-acting contraceptive API segment is expected to hold a major global market share[4].

4. What are the key driving factors of the levonorgestrel market? Increasing awareness among people, innovative products, and robust medical care infrastructure are key driving factors[2][3].

5. Which region is expected to dominate the global levonorgestrel market? North America is expected to hold a significant revenue share, but the Asia Pacific region is projected to grow rapidly[4].

Sources

  1. Cognitive Market Research: Global Levonorgestrel Market Report.
  2. Business Research Insights: Levonorgestrel Market Size, Share | Analysis Report, 2032.
  3. iHealthcareAnalyst: Global Hormonal Contraceptives Market.
  4. InsightAce Analytic: Levonorgestrel API Market.
  5. Drugs.com: Levonorgestrel Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.